Navigation Links
Ker Govt To Adopt Orphaned Kids Of HIV Infected Parents

Eight-year-old twins Amal and Amrutha, who became orphaned after their HIV-infected parents died four years ago, will be formally adopted by the Kerala Government at a function here tomorrow //.

The function, being organised by Cheruvathur Grama Panchayat to completely take care of the children's health, education and welfare, would be inaugurated by Health and Social Welfare Minister P K Sreemati, who at a recent Cabinet meeting mooted the idea of adopting the children, Grama Panchayat president Munambath Govindan said today.

The plight of Amal, who is HIV positive, and his sister Amrutha, studying in class three in a local government school, got worsened after their grandmother Janaki, who had been looking after them since the demise of their parents in 2002, died of old age last month.

The twins had since been staying in their house near here, constructed at the initiative of Grama Panchayat Committee at a cost of Rs 9.50 lakhs nine months ago, and were occasionally helped by their mother's younger sister Shylaja.

The children's case was then taken up by +Keraleeyam+, an organisation under the state Social Welfare Department under +Navajeevanam+ scheme, which arranged furniture and other items at a cost of Rs 75,000 after the government gave the nod for adopting the children a few days ago.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. Adopting Easier Methods To Screen Insulin Resistance
2. Diabetics Should Adopt Better Preventive Measures
3. Poultry Workers To Adopt Anti-Flu Guidelines
4. Exiled Tibetans In India To Adopt Organic Farming
5. Kerala Govt To Adopt Orphaned Kids Of HIV Infected Parents
6. Sex Workers Adopt IT Solutions to Fight AIDS
7. Gates Foundation Adopts Fight against Encephalitis
8. Vice President Urges Dental Institutes to Adopt Some Villages
9. Haryana Adopts New Rules for Private Schools
10. China Bars Obese from Adopting Children
11. Plan to Adopt Vaccine Purchase Plan for Diseases

Post Your Comments:
(Date:11/23/2009)...n Washington D.C. , NewYorkCity , LosAngel...GrowthandRevitalization ,, WASHINGTON,Nov.23 ...ngproviderofdialysisservices,todaywaslaudedbyD.C.o...lioninvestmentinIndustrialBankaspartofaninitiative...a,sinvestmentinWashington,D.C.ispartofthedialysisc...
(Date:11/23/2009)..., WHAT: ,, TheBerylInstitute, theresearchan...adinghealthcareexclusivecallcenter,issponsoringafr...nerationwithapositivecustomerserviceexperience.Hos...arwillsupplementHowe,sJune2009whitepaper,"Customer...showconsumerswillultimatelytransformhealthcaredeli...
(Date:11/23/2009)...istheeconomyaffectingpeople,swellness?Accordingtoa...amp;theEconomy,theeconomyismakinguscollectivelymor...rciseanddiettoonethatismoreinwardlyfocusedonadapti...amaticfindingwasthechangeinconsumers,definitionofw...ndwellbeingtotoday,smorerelevantconcernsaboutadapt...
(Date:11/23/2009)...eases Society of America (IDSA) has asked for a co...opean Union to further the Society,s mission to ac... the next 10 years, known as the 10 x ,20 Initiati...ified antimicrobial resistance as one of the three...ean Union report confirms there are just 15 antiba...
(Date:11/23/2009)...--ThousandsofpeoplewithiPhoneshavealreadydownloade...etesbettermanagetheirdiseasethroughabetterundersta...rmanagetheirbloodsugar.Nowit,sbecomeeveneasierthro..., RocheDiabetesCare,themakeroftheACCU-CHEK®li...spartneredwithMYLEstoneHealth,thedeveloperofGlucos...
Breaking Medicine News(10 mins):Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3
...ncy-related blood pressure condition can pose seri...RIDAY, Oct. 17 (HealthDay News) -- Pregnant with h...minal pain and headaches until her symptoms worsen...is one of hundreds of women whose brush with preec...
...cademy of Ophthalmology hosts event October 24 ben... Sullivan headlines event, OKLAHOMA CITY, Oct. 17...e second annual "Eye Ball," benefiting the,Juvenil...Gary Story of Oklahoma City are the honorary chair...
...t. 17 American Well today announced that CEO,Roy ...product management;,and Michael Stollar, vice pres...s Blue Shield of Hawaii (HMSA), will provide a liv...t 10:00,a.m. PDT on October 23, 2008 at San Franci...
..., Calif., Oct. 17 Wyle is a key partner in,the wi...Center contract to,provide occupational health ser...year contract, valued at up to $24 million, is due...ealth physics,and respiratory protection., "We ar...
...sunderstand written screening tools, but ,talking,...17 (HealthDay News) -- Many patients misunderstand...answer before physical exams, a finding that calls...he American College of Surgeons, found that lower-...
...TON, Oct. 17 After a destructive,hurricane season... for,disasters, the American Public Health Associa...d ones are prepared for winter storms and any othe...make sure their emergency preparedness kits are st...
Other Medicine News:Health News:Research May Help Predict Preeclampsia 2Health News:Research May Help Predict Preeclampsia 3Health News:Research May Help Predict Preeclampsia 4Health News:Second Annual 'Eye Ball' Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology 2Health News:Second Annual 'Eye Ball' Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology 3Health News:American Well Systems CEO Roy Schoenberg to Present Live Public Demo of First Online Care Service at Health 2.0 Conference 2Health News:Wyle Key Part of Winning Team for Marshall Space Flight Center Occupational Health Services Contract 2Health News:Doctors Often Overestimate Patients' Health Literacy 2Health News:Check Your Emergency Preparedness Kits When You Set Your Clocks, Says American Public Health Association Campaign 2
(Date:11/23/2009)...re-FirstCall/--WoundManagementTechnologies,Inc.,(O...ialtymedicalproducts,announcedthatithasfileditQ320...gementbusinessupdatetoillustratethedevelopmentsdur...d33.5%to$102,926vs.Q32008salesof$77,084. , Sh...s.Q32008shareholderequityof$(321,257) , Total...
(Date:11/23/2009)...tCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:CBA...y( http://www.cordblood-america.com )focusedonbrin...nsurancepolicy,tofamiliesnationwideandinternationa...thCEOandco-founderMatthewSchisslerisnowavailable. ...2875811 . ,, Intheinterview,Mr.Schisslerupdates...
(Date:11/23/2009)...-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"ort...tationofclinicaltrialdataonNGX426,theCompany,soral...gonist,atthe12thInternationalConferenceontheMechan...-21inSanFrancisco.TheresultsofthestudyledbyMarkWal...nterforPainMedicineoftheUniversityofCaliforniaatSa...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 1Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 2Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 3CoAxia Inc Announces 2421 5M Series D Financing 4628 1CoAxia Inc Announces 2421 5M Series D Financing 4628 2CoAxia Inc Announces 2421 5M Series D Financing 4628 3Lilly Declares Third Quarter Dividend 49687 1
...e II study extension shows 68-73% of patients with... three years of treatment with oral FTY720,- New d...rain lesions - the injury caused by MS - thr...ating disease causing progressive disability, affe...g many young adults - FTY720 regulatory filings p...
... MEK inhibitor, RDEA119, demonstrates potential fo...nary Phase 1 results -, - Next generation MEK inh... half of 2008 -, SAN DIE...EA ) today announced that data was presented demon...okinetic profile of the Company,s,mitogen-activate...
Other Medicine Technology:FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 2FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 3FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 4FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 5FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 6Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 2Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 3Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 4
Polymax
Sononav Intraoperative Imaging System
...the two steps are performed in sequence automatica...use disposable cartridge and placed in the dual ac... the cycle begins. The platelet plasma is separate...p concentrates fibrinogen, platelets and all other...
Syringe Avitene
Medicine Products: